Published on
April 29, 2026
- 10:26 GMT
EyeCool Therapeutics Announces New ETX-4143 Data to Be Presented at ARVO 2026
Presentations add to growing evidence supporting safety and efficacy of this novel device in chronic ocular surface pain. BOSTON, MA, UNITED STATES, April 29, 2026 /EINPresswire.com/ -- EyeCool Therapeutics today announced that new data on its …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
